For the quarter ending 2025-10-31, SAIC had -$3M decrease in cash & cash equivalents over the period. $120M in free cash flow.
| Cash Flow | 2025-10-31 | 2025-08-01 |
|---|---|---|
| Net income | 78 | 195 |
| Depreciation and amortization | 38 | 71 |
| Stock-based compensation expense | 26 | 25 |
| Deferred income taxes | -8 | 109 |
| Gain on sale of equity method investments | 0 | - |
| Other | 4 | 0 |
| Receivables | 80 | -49 |
| Prepaid expenses and other current assets | -39 | 107 |
| Accounts payable and other accrued liabilities | 62 | -84 |
| Accrued payroll and employee benefits | -33 | -3 |
| Operating lease assets and liabilities, net | -1 | -4 |
| Other assets and other long-term liabilities, net | 12 | -29 |
| Net cash provided by operating activities | 129 | 222 |
| Cash paid for acquisitions, net of cash acquired | 203 | - |
| Expenditures for property, plant, and equipment | 9 | 15 |
| Purchases of marketable securities | 1 | 4 |
| Sales of marketable securities | 1 | 4 |
| Proceeds from sale of equity method investments | 0 | - |
| Contributions to investments | 3 | 7 |
| Net cash used in investing activities | -215 | -22 |
| Proceeds from borrowings | 1,438 | 1,307 |
| Principal payments on borrowings | 1,238 | 1,235 |
| Stock repurchased and retired or withheld for taxes on equity awards | 95 | 252 |
| Dividend payments to stockholders | 17 | 36 |
| Issuances of stock | 4 | 12 |
| Debt issuance costs | 9 | - |
| Other | 0 | -4 |
| Net cash used in financing activities | 83 | -208 |
| Net decrease in cash, cash equivalents and restricted cash | -3 | -8 |
| Cash and cash equivalents at beginning of period | 64 | - |
| Cash and cash equivalents at end of period | 53 | - |
Science Applications International Corp (SAIC)
Science Applications International Corp (SAIC)